Go to main content

Types of Collaboration

GC Pharma continues to
Strengthen and diversify
Partner relations.

Photo that shows partnership


In addition to maximizing the efficiency of its own research organization, GC Pharma has also been generating significant R&D synergy and open innovation through active exchange and collaboration with academia, innovative biotechnology startups, and leading global pharmaceutical companies. GC Pharma’s partners in and outside Korea continue to give the company an edge over its technological competition on the global biotechnology market and enable it to reinforce its R&D pipeline.

GC Pharma Looks for Partners Interested in Jointly Expanding R&D Pipelines Together

GC Pharma continues to seek to work with companies experienced in researching and developing biological products, including vaccines, plasma derivatives, and recombinant proteins; companies possessing infrastructure to support biological product research; companies committed to developing products for in-licensing; and companies with experience and capabilities in commercializing in-licensed products.


GC Pharma has extensive experience with the R&D of biological agents, such as vaccines, plasma derivatives, and recombinant proteins, employs professional R&D resources and possesses the capabilities for licensing, clinical trials, and business relations concerning such products. Throughout-licensing, GC Pharma allows its partners to access the expertise of the company’s R&D and clinical trial divisions as well as its competitive products. Under its mid- to long-term global growth strategy, GC Pharma is actively looking for potential opportunities for partnership over the products and technologies it is researching/developing or has already released on the market.


GC녹십자는 이메일 수집을 거부합니다

본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나
그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,
이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을
유념하시기 바랍니다

게시일: 2003년 9월 1일